PH News

Pulnovo Raises Millions to Develop Its PAH Device and Trials

Pulnovo Medical recently raised an undisclosed amount totaling millions of dollars in investment funding to support clinical trials and product development related to pulmonary arterial hypertension (PAH). “The road of global medical innovation has never been an easy journey,” Cynthia Chen, Pulnovo’s executive president, said in a…

PH Not Common Disease, Population Study Finds, But Groups at Risk

The likelihood of developing pulmonary hypertension (PH) is low among people in southern Italy, a study drawn from a random and large grouping of individuals with echocardiograms, done to determine disease prevalence, suggested. Independent predictors of PH include female sex and right ventricular enlargement, its scientists noted. The study, “…

Support Groups May Help Patients Better Manage Symptoms

Joining support groups — meeting people with common experiences and concerns who can provide emotional reassurance — for pulmonary hypertension (PH) helped patients manage symptoms, stick to medicines, and better understand their disease, a study reports. Participation in a support group, however, had no impact on the general quality…

CIT GAP Funds Invests in OxiWear Device for PH Patients

The Center for Innovative Technology (CIT) GAP Funds has invested in OxiWear and its ear-wearable device designed to continuously monitor blood oxygen levels in people with pulmonary hypertension (PH) and alert them when levels fall below safe thresholds. Oxiwear is expected to help patients get the help they…